Evidence map›Paper›PMID 30737148›Full record

ArticleImmunity2019

Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.

Julia A Brown, Gursewak Singh, Joshua A Acklin, Silviana Lee, James E Duehr, Anupa N Chokola, Justin J Frere, Kevin W Hoffman, Gregory A Foster, David Krysztof and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Mechanisms of Zika astrocyte infection and neuronal toxicity.NeuroImmune pharmacology and therapeutics · 2023
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Julia A BrownDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gursewak SinghDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Joshua A AcklinDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Silviana LeeDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
James E DuehrDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Anupa N ChokolaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Justin J FrereDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kevin W HoffmanDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gregory A FosterAmerican Red Cross, Gaithersburg, MD, USA.
David KrysztofAmerican Red Cross, Gaithersburg, MD, USA.
Richard CadaganDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Adam R JacobsDepartment of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Susan L StramerAmerican Red Cross, Gaithersburg, MD, USA.
Florian KrammerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jean K LimDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: jean.lim@mssm.edu.
Icahn School of Medicine at Mount Sinai · USAmerican Red Cross · US

Funding

Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodiesR01AI150837 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2020 to 2024
$2.1M
Interferon signaling inhibition by the Zika virus NS5 proteinR21AI129486 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2017 to 2018
$466k
Impact of pre-existing dengue virus immunity on Zika virus infection of placentaR21AI139593 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2018 to 2019
$465k
Determining West Nile virus antibody-dependent enhancement of Zika virusR21AI130299 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2017 to 2018
$464k
Human Ex Vivo Models of Zika Virus InfectionR21AI127955 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2017 to 2018
$464k
NIAID NIH HHS R01 AI150837NIAID NIH HHS R21 AI127955NIAID NIH HHS R21 AI129486NIAID NIH HHS R21 AI130299NIAID NIH HHS R21 AI139593NIAID NIH HHS T32 AI007647NIAID NIH HHS U19 AI118610
6 · The paper itself

Abstract

Zika virus (ZIKV) has recently been associated with birth defects and pregnancy loss after maternal infection. Because dengue virus (DENV) and ZIKV co-circulate, understanding the role of antibody-dependent enhancement in the context of pregnancy is critical. Here, we showed that the presence of DENV-specific antibodies in ZIKV-infected pregnant mice significantly increased placental damage, fetal growth restriction, and fetal resorption. This was associated with enhanced viral replication in the placenta that coincided with an increased frequency of infected trophoblasts. ZIKV-infected human placental tissues also showed increased replication in the presence of DENV antibodies, which was reversed by FcγR blocking antibodies. Furthermore, ZIKV-mediated fetal pathogenesis was enhanced in mice in the presence of a DENV-reactive monoclonal antibody, but not in the presence of the LALA variant, indicating a dependence on FcγR engagement. Our data suggest a possible mechanism for the recent increase in severe pregnancy outcomes after ZIKV infection in DENV-endemic areas.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralAntibody-Dependent EnhancementCell Line, TumorChlorocebus aethiopsCross ReactionsDengue VirusFemaleHumansImmunityK562 CellsMicePregnancyVero CellsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, Viralantibodiesantibody-dependent enhancementdengue virusflaviviruspathogenesisplacentapregnancytrophoblastsZika virus

Identifiers

PMID30737148
PMCPMC6947917
OpenAlexW2911726030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.